ArticleAnnals of hematology2022

Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil.

Kazuki Sakatoku et al.PubMed ↗Publisher ↗

No numbers read from the abstract.